Par Drugs and Chemicals (NSE:PAR) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Par Drugs and Chemicals's Free Cash Flow for the three months ended in Mar. 2024 was ₹0.0 Mil. Par Drugs and Chemicals's Revenue for the three months ended in Mar. 2024 was ₹228.2 Mil. Therefore, Par Drugs and Chemicals's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Par Drugs and Chemicals's current FCF Yield % is 4.94%.

The historical rank and industry rank for Par Drugs and Chemicals's FCF Margin % or its related term are showing as below:

NSE:PAR' s FCF Margin % Range Over the Past 10 Years
Min: 5.95 Med: 9.94 Max: 15.76
Current: 14.81

During the past 8 years, the highest FCF Margin % of Par Drugs and Chemicals was 15.76%. The lowest was 5.95%. And the median was 9.94%.

NSE:PAR's FCF Margin % is ranked better than
83.5% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.13 vs NSE:PAR: 14.81

Par Drugs and Chemicals FCF Margin % Historical Data

The historical data trend for Par Drugs and Chemicals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Par Drugs and Chemicals FCF Margin % Chart

Par Drugs and Chemicals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

11.13

11.75

5.95

6.00

14.81

Par Drugs and Chemicals Quarterly Data
	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Par Drugs and Chemicals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Par Drugs and Chemicals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Par Drugs and Chemicals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Par Drugs and Chemicals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Par Drugs and Chemicals's FCF Margin % falls into.

Par Drugs and Chemicals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Par Drugs and Chemicals's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	141.686	/	956.404
	=	14.81 %

Par Drugs and Chemicals's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	228.192
	=	0.00 %

Par Drugs and Chemicals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Par Drugs and Chemicals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Par Drugs and Chemicals (NSE:PAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007

Website

https://www.pardrugs.com

Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage.